Skip to main content
Year archive

Moberg Pharma — 2018 filings

All 53 regulatory filings released by Moberg Pharma (MOB) in 2018, sourced directly from the official regulator.

53 Filings
2018 Period
2018 filings (53)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-11-26 English
Patent beviljat för MOB-015 i Kina
Regulatory Filings
2018-11-23 Swedish
Patent granted for MOB-015 in China
Regulatory Filings
2018-11-23 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-21 English
Moberg Pharmas valberedning utsedd
Governance Information
2018-11-08 Swedish
Moberg Pharma’s nomination committee appointed
Board/Management Information
2018-11-08 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-06 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-06 English
Moberg Pharma signs exclusive agreement for Emtrix® in the Middle East and Africa
Regulatory Filings
2018-11-05 English
Moberg Pharma ingår exklusivt avtal för Emtrix® i Mellanöstern och Afrika
Regulatory Filings
2018-11-05 Swedish
Moberg Pharmas rapport för tredje kvartalet presenteras 6 november - Inbjudan till telefonkonferens
Report Publication Announcement
2018-10-30 Swedish
Moberg Pharma’s report for the third quarter to be published on November 6 - Invitation to teleconference
Report Publication Announcement
2018-10-30 English
Moberg Pharma och Cipher Pharmaceuticals ingår exklusivt licensavtal för MOB-015 i Kanada
Regulatory Filings
2018-09-18 Swedish
Moberg Pharma and Cipher Pharmaceuticals sign exclusive license agreement for MOB-015 in Canada
Regulatory Filings
2018-09-18 English
Moberg Pharma har slutfört rekryteringen till fas 3-studien för MOB-015 i Nordamerika
Regulatory Filings
2018-09-11 Swedish
Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North America
Earnings Release FY 2018
2018-09-11 English
Moberg Pharma utser ny Chief Medical Officer
Board/Management Information
2018-08-13 Swedish
Appointment of Chief Medical Officer at Moberg Pharma
Board/Management Information
2018-08-13 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-07 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-07 English
Moberg Pharmas rapport för andra kvartalet presenteras 7 augusti - Inbjudan till telefonkonferens
Report Publication Announcement
2018-07-30 Swedish
Moberg Pharma’s report for the second quarter to be published on August 7 - Invitation to teleconference
Report Publication Announcement
2018-07-30 English
New number of shares and votes in Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-06-29 English
Ändring av antalet aktier och röster i Moberg Pharma AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-06-29 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-06-28 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-06-14 English
Kommuniké från Moberg Pharmas årsstämma 2018
AGM Information
2018-05-15 Swedish
Bulletin from Moberg Pharma’s AGM 2018
AGM Information
2018-05-15 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-08 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-08 English
U.S. patent granted for BUPI
Regulatory Filings
2018-05-02 English
Patent beviljat för BUPI i USA
Regulatory Filings
2018-05-02 Swedish
Moberg Pharma completes divestment of Balmex® for $4.25 million
M&A Activity
2018-04-27 English
Moberg Pharma slutför avyttringen av Balmex® för 4,25 MUSD
M&A Activity
2018-04-27 Swedish
Moberg Pharma’s report for the first quarter to be published on May 8 - Invitation to teleconference
Report Publication Announcement
2018-04-26 English
Moberg Pharmas rapport för första kvartalet presenteras 8 maj - Inbjudan till telefonkonferens
Report Publication Announcement
2018-04-26 Swedish
Management change in Moberg Pharma
Board/Management Information
2018-04-19 English
Ledningsförändring i Moberg Pharma
Board/Management Information
2018-04-19 Swedish
Notice of Annual General Meeting in Moberg Pharma AB (publ)
AGM Information
2018-04-10 English
Kallelse till årsstämma i Moberg Pharma AB (publ)
AGM Information
2018-04-10 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-10 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-10 English
Valberedningens förslag till årsstämman 2018
AGM Information
2018-03-13 Swedish
The Nomination Committee’s proposal to the Annual General Meeting 2018
AGM Information
2018-03-13 English
Moberg Pharma divests Balmex® for $4.25 million
M&A Activity
2018-02-28 English
Moberg Pharma avyttrar Balmex® för 4,25 MUSD
Capital/Financing Update
2018-02-28 Swedish
Earnings Release 2017
Earnings Release FY 2017
2018-02-13 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report FY 2017
2018-02-13 English
Moberg Pharmas bokslutskommuniké presenteras 13 februari - Inbjudan till telefonkonferens
Report Publication Announcement
2018-02-06 Swedish
Moberg Pharma’s Year-end report to be published on February 13 - Invitation to teleconference
Report Publication Announcement
2018-02-06 English
Moberg Pharma får bifall från NAD – huvudkonkurrent upphör med nuvarande marknadsföring
Regulatory Filings
2018-01-15 Swedish
Moberg Pharma receives favorable outcome from NAD – main competitor to discontinue current marketing
Legal Proceedings Report
2018-01-15 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-01-12 English